← Leaderboards
Rachel L Damico
Johns Hopkins University
$3,481,087
Attributed
$6,815,775
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $816.3K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,815,775 · 5
By mechanism
R01$5,636,867 · 2
K08$677,700 · 1
R56$405,000 · 1
F32$96,208 · 1
Top collaborators
- Franco Rafael D'Alessio4 shared
- Paul M Hassoun4 shared
- Srinivasan Yegnasubramanian4 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Irina Petrache$14,015,590
- Enid R Neptune$11,248,461
- Mary Y. Armanios$14,372,703
- Zaver M Bhujwalla$35,375,851
- Peter Louis Gehlbach$2,476,888
Others in their field
Top investigators on “In Vitro”
- David Heimbrook · Leidos Biomedical Research, Inc.$553,787,942
- Leonard Freedman · Leidos Biomedical Research, Inc.$310,441,779
- Mark S Klempner · Tufts Medical Center$128,021,180
- Florian Krammer · Icahn School Of Medicine At Mount Sinai$104,723,856
- Lynn Briscoe · Leidos Biomedical Research, Inc.$94,686,873
- Dennis R. Burton · Scripps Research Institute$79,204,175
Research focus
In VitroLungMolecularHomeostasisIn VivoDisease ModelRegulationCytokineResponseInjuryProteinsLung InjuryPlayAcuteCessation Of LifeSeverity Of IllnessInfectionCellsPathway InteractionsPhysiologicalEventProgramsResearch PersonnelTherapeutic Target
Grant awards (16)
Targeting Estrogenic pathways in Tregs to promote ARDS resolution - 5R01HL163881$684,280
R01 · FY2025 · HL
Targeting Estrogenic pathways in Tregs to promote ARDS resolution$787,156
R01 · FY2024 · HL
Targeting Estrogenic pathways in Tregs to promote ARDS resolution$809,772
R01 · FY2023 · HL
Targeting Estrogenic pathways in Tregs to promote ARDS resolution$816,322
R01 · FY2022 · HL
Functional Impact of Col18a1/Endostatin Variants in PAH$594,522
R01 · FY2020 · HL · contact PI
Functional Impact of Col18a1/Endostatin Variants in PAH$631,666
R01 · FY2019 · HL · contact PI
Functional Impact of Col18a1/Endostatin Variants in PAH$644,325
R01 · FY2018 · HL · contact PI
Functional Impact of Col18a1/Endostatin Variants in PAH$668,824
R01 · FY2017 · HL · contact PI
Novel determinants of alveolar homeostasis and their contribution to emphysema$405,000
R56 · FY2014 · HL · contact PI
Regulators of Endothelial Cell Apoptosis in LPS-Induced Acute Lung Injury$135,540
K08 · FY2012 · HL · contact PI
Regulators of Endothelial Cell Apoptosis in LPS-Induced Acute Lung Injury$135,540
K08 · FY2011 · HL · contact PI
Regulators of Endothelial Cell Apoptosis in LPS-Induced Acute Lung Injury$135,540
K08 · FY2010 · HL · contact PI
Regulators of Endothelial Cell Apoptosis in LPS-Induced Acute Lung Injury$135,540
K08 · FY2009 · HL · contact PI
Regulators of Endothelial Cell Apoptosis in LPS-Induced Acute Lung Injury$135,540
K08 · FY2008 · HL · contact PI
The Role of MIF in Endothelial Apoptosis$45,660
F32 · FY2005 · HL
The Role of MIF in Endothelial Apoptosis$50,548
F32 · FY2004 · HL